Skip to content

HLL Pays Record Rs. 69.5 Cr Dividend to Govt for FY 2024-25

PRESS NEWS NETWORK

HLL Lifecare Limited, a Mini-Ratna CPSE under the Ministry of Health & Family Welfare, has paid a record dividend of Rs. 69.53 crore to the Government of India for the financial year 2024–25. Union Health Minister Shri J.P. Nadda praised HLL’s role in providing accessible, affordable, and quality healthcare. This milestone highlights HLL’s robust financial growth and its contributions to India’s healthcare transformation.

Dividend Presentation Ceremony

The dividend cheque was presented to Shri J.P. Nadda, Hon’ble Union Minister of Health & Family Welfare, by Dr. Anitha Thampi, Chairperson, HLL, in the presence of Smt. Anupriya Patel, Minister of State for Health & Family Welfare; Smt. Punya Salila Srivastava, Union Health Secretary; Shri Hovyeda Abbas, AS&FA; and Shri Vijay Nehra, Joint Secretary, Ministry of Health & Family Welfare. Senior officials from HLL, including Shri N. Ajit, Director (Marketing), and Shri Ramesh P, Director (Finance), were also present.

HLL Dividend Presentation Ceremony

Image Source: PIB Delhi

HLL’s Role in Healthcare Transformation

Speaking at the occasion, Shri J.P. Nadda asserted that, HLL is a reliable name in the field of Medical Services and is committed towards the national vision of accessible, affordable and quality healthcare to all.

Impact of AMRIT Pharmacies

Commending HLL’s performance, Shri J.P. Nadda, stated that, HLL along with its subsidiaries and Amrit pharmacies have emerged as a key player in transforming the health sector. He highlighted that in the last 10 years, over 6.7 crore people have benefited through the affordable medicines of the Amrit Pharmacies, thereby saving more than Rs. 8000 Crores in terms of their out-of-pocket expenditure.

HLL’s Contribution to Healthcare

Image Source: PIB Delhi

Financial Performance in FY 2024-25

The financial year 2024–25 witnessed comprehensive growth across both HLL’s manufacturing and service portfolios. Revenue from operations increased to Rs. 4,500 crore, reflecting a 20% growth over the previous year. The company’s net worth rose significantly to Rs. 1,100 crore as on March 31, 2025.

Consolidated Growth

On a consolidated basis, including its subsidiaries — HITES, GAPL, and Lifespring Hospitals — the HLL Group recorded a total revenue of Rs. 4,900 crore, marking a 19% growth over the previous fiscal.

Background of HLL Lifecare Limited

Established on 1st March 1966, HLL Lifecare Limited has evolved from addressing India’s population control challenges to becoming a multi-product, multi-service healthcare enterprise playing a pivotal role in the nation’s health sector transformation. Through initiatives such as AMRIT Pharmacies, the company continues to make essential medicines and surgical products affordable, thereby reducing out-of-pocket expenses for patients across the country.

HLL’s Healthcare Initiatives

Image Source: PIB Delhi

As HLL celebrates its 60th year, it reaffirms its commitment for delivering quality healthcare solutions, contributing to accessible, affordable, and equitable healthcare for all.

Source

Posted On: 25 OCT 2025 5:31PM by PIB Delhi




Leave a Reply